Objective: Hypertension may lead to left ventricular hypertrophy, fibrosis and degeneration of the conduction system. Our aim was to study the association of hypertrophy with certain arrhythmias such as complete atrioventricular block (AVB) and symptomatic sick sinus syndrome (SSS) that require implantation of permanent pacemaker. Methods: We studied 130 patients that had been given a pacemaker because of complete AVB, 130 patients that had been given a pacemaker because of symptomatic SSS and 45 patients without cardiac conduction disturbances. In order to estimate left ventricular hypertrophy, indexes of relative wall thickness (RWT) and left ventricular mass (LVM) were evaluated by echocardiography. Results: We observed significant association between complete AVB and abnormal values of echocardiographic indexes. Conclusions: Our results lend further support to the hypothesis that complete AVB is associated with left ventricular hypertrophy. This hypothesis is enhanced by the observation that the majority of patients with complete AVB were hypertensive.
Introduction
Hypertension affects one quarter of the United States adult population and is adequately treated in less than 30% of them [August, 2003] . The percentage of optimal therapy is even lower in major European countries [Wolf-Maier et al. 2003] . Hypertension is associated with left ventricular hypertrophy which is an adaptive response to pressure overload that may result in myocardial dysfunction and congestive heart failure. Microscopically, the earliest change of systemic hypertensive heart disease is an increase in the transverse diameter of myocytes. At advanced stages, interstitial fibrosis is obvious [Schoen, 2005; Mccrossan et al. 2004; Verdecchia et al. 1998 ]. Several studies suggest that increased left ventricular mass (LVM) and hypertrophy are associated with increased risk for arrhythmias and sudden death [Haider et al. 1998; Cooper et al. 1990 ].
Atrioventricular block (AVB) comprises a significant electrophysiological disorder which is related to delay or interruption in propagation of an impulse from the atria to the ventricles due to an anatomical or functional impairment in the conduction system. Complete AVB can result from block at the level of the atrioventricular node, within the bundle of His (intrahisian), or distal to it in the Purkinje system (infrahisian) [Olgin and Zipes, 2005] .
Sick sinus syndrome (SSS) is another electrophysiological disturbance related to alternating bradycardia and atrial tachyarrhythmias. It may be associated with profound clinical features due to severe bradycardia, sinus pauses, arrest and exit block with, and often without, appropriate atrial and junctional escape rhythms [Ferrer, 1973] .
Previous studies have shown that ventricular hypertrophy is related mainly to ventricular arrhythmias [Wolk, 2000; Messerli and Grodzicki, 1992; Ghali et al. 1991; Mclenachan et al. 1987] and increase of intraventricular delay [Xiao et al. 1994] . In order to lend further support to the hypothesis that remodelling of the left ventricle may be associated with conduction disturbances, we studied echocardiographically patients that had been given a pacemaker because of symptomatic complete AVB and SSS.
Materials and methods

Study group
The current study included 130 patients that had been given a pacemaker because of symptomatic complete AVB, 130 patients that had been given a pacemaker because of symptomatic SSS and 45 control subjects.
Eligible for inclusion in the study were men and women who presented with symptomatic complete AVB or SSS of nonischaemic origin and had no history of coronary artery disease (CAD). Patients with aortic valve sclerosis and stenosis, hypertrophic cardiomyopathy and chronic kidney disease were excluded from current study.
Control subjects were selected from men and women who were hospitalized for evaluation of chest pain and clinical or laboratory investigation showed no evidence of CAD.
Patients baseline characteristics are presented in Table 1 .
Definitions
Medical records were reviewed for presence of certain risk factors such as hypertension, diabetes mellitus (DM), dyslipidaemia, smoking and family history of CAD.
Hypertension was defined as systolic blood pressure >140 mmHg, diastolic blood pressure >90 mmHg or use of antihypertensive medication.
DM was defined as use of an oral hypoglycaemic agent or insulin, fasting glucose >126 mg/dl or postchallenge glucose >200 mg/dl (75 g oral glucose tolerance test).
Dyslipidaemia was defined as a high-density lipoprotein (HDL) concentration <45 mg/dl in men or <55 mg/dl in women, a total cholesterol concentration !200 mg/dl, a low-density lipoprotein (LDL) concentration !100 mg/dl, or a fasting triglyceride concentration !200 mg/dl or as having ever been prescribed medication for high cholesterol.
Smoking was defined as regular daily cigarette smoking or having stopped in the previous 12 months.
Family history of CAD was defined as firstdegree relatives (parents, brothers and/or sisters) with myocardial infarction before age 60 or stroke at any age.
Electrophysiology
Electrophysiologic study was performed after the patients had fasted for >6 h and all kinds of cardiovascular drugs were discontinued 2 days before the test.
Diagnostic results included prolonged corrected sinus node recovery time (>550 ms) as indicative of sinus node disease, prolonged HV interval (>100 ms), supraventricular tachycardia >180 ) to yield muscle mass in grams:
where IVS is interventricular septal thickness [Foppa et al. 2005; Devereux et al. 1986] . The cutoff values for left ventricular hypertrophy were 131 g/m in men and 100 g/m in women.
All of the echocardiographic recordings were made on a Toshiba Powervision machine.
Study protocol
The aim of our study was to find an association between serious arrhythmias such as complete AVB and SSS and presence of left ventricular hypertrophy. Left ventricular hypertrophy was estimated by evaluating echocardiographically indexes of RWT and LVM. In order to confirm the validity of our results, we studied the relation between left ventricular hypertrophy and presence of cardiovascular risk factors especially hypertension.
Data analysis
Statistical analysis was performed with SPSS for Windows, release 12.0 (SPSS inc, Chicago, IL, USA). Ordinal data were assessed with nonparametric tests. The significance of differences among groups was tested with MannWhitney U-test. Correlations between certain parameters were evaluated by the Spearman rank-order correlation coefficient. The significance level was defined as p < 0.05.
Results
The majority of normal subjects had no sign of left ventricular hypertrophy presenting normal indexes of RWT and LVM.
Among patients with SSS, few of them presented abnormal indexes of RWT (n ¼ 6 (4.6%)) and LVM (n ¼ 14 (10.7%)). These indexes were not statistically different in relation to controls. Moreover, there was no association between presence of SSS and certain cardiovascular risk factors such as hypertension, DM, dyslipidaemia, smoking and family history of CAD.
Majority of patients with complete AVB had left ventricular hypertrophy. Ninety patients (69%) had abnormal index of RWT and 109 patients (84%) had abnormal index of LVM. Among patients with complete AVB, 81 of them presented infrahisian block during electrophysiologic testing. These patients presented higher percentage of abnormal indexes of RWT (n ¼ 70 (86%)) and LVM (n ¼ 76 (94%)), respectively. The indexes in patients with complete AVB were statistically different in relation to patients with SSS (p < 0.05). Overall, RWT and LVM indexes correlated statistically with the presence of hypertension in patients with complete AVB (r ¼ 0.649, p < 0.001 and r ¼ 0.670, p < 0.001, respectively). Moreover, there was correlation between LVMI and smoking in men (r ¼ 0.256, p < 0.05). Finally, statistical process showed significant association between the presence of complete AVB and hypertension (p < 0.001). The presence of other risk factors such as DM, dyslipidaemia, smoking and family history of CAD did not relate with the presence of complete AVB.
Discussion
Left ventricular hypertrophy has been traditionally linked to ventricular arrhythmias [Wolk, 2000; Messerli and Grodzicki, 1992; Ghali et al. 1991; Mclenachan et al. 1987] . The current project studied the prevalence of hypertrophy in patients with complete AVB and SSS requiring implantation of a permanent pacemaker. Our results demonstrated a significant association between left ventricular hypertrophy indexes and the presence of complete AVB.
It is known that remodelling of the left ventricle alters the electrical properties of heart tissue [Bodi et al. 2003; Wang et al. 2001; Tomaselli and Marban, 1999] . Left ventricular hypertrophy may induce pro-arrhythmic events through myocardial ischaemia [Wolk, 2000] . Myocardial ischaemia is associated with atherosclerosis of coronary arteries in presence of hypertension, which comprises an independent risk factor for CAD. It may also occur as the result of perivascular fibrosis and a reduction in coronary flow reserve. Combination of myocardial ischaemia and mechanical stretch may have profound electrophysiological effects and produce arrhythmias.
Previous studies have shown that electrical remodelling associated with hypertrophy causes an increased frequency of ventricular ectopy and aberrant conduction [Reddy et al. 2003; Xiao et al. 1994] . More recent evidence suggests that severe hypertrophy is characterized by delayed conduction, resulting from an increase in junctional resistance [Bacharova et al. 2009] . Decreased levels of connexin 43 in chronic myocardial hypertrophy lend further support to this hypothesis [Bacharova et al. 2008] . In order to provide additional evidence that ventricular remodelling may be associated with serious arrhythmias requiring pacemaker implantation we studied presence of hypertrophy in patients with complete AVB and SSS. As we mentioned previously, our findings are consistent with the hypothesis that ventricular hypertrophy may be associated with major conduction disturbances such as high degree AVB. This association was even stronger in patients with infrahisian block suggesting that anatomical remodelling of the left ventricle exerts unfavourable effects on impulse propagation. Moreover, RWT and LVMI were associated substantially with arterial hypertension in patients with complete AVB suggesting that findings were not circumstantial.
Advanced age and DM have been implicated in development of conduction disturbances [Gueli et al. 2010; Movahed et al. 2005] . In addition, previous reports suggest that DM may contribute to left ventricular hypertrophy [Eguchi et al. 2008; Dawson et al. 2005; Tenenbaum et al. 2003 ]. The current study included patients with complete AVB that were younger in relation to patients with SSS, so age cannot be considered as a confounding factor. Regarding patients suffering from DM, we repeated statistical process excluding them from study population. We found again that RWT and LVMI in patients with complete AVB correlated statistically with presence of hypertension (r ¼ 0.541, p < 0.001 and r ¼ 0.453, p < 0.001, respectively) and were statistically different in relation to patients with SSS (p < 0.001).
The current study showed the minimal presence of left ventricular hypertrophy in patients with SSS despite the fact that a considerable number of them were hypertensive. Considering that atria and ventricles are linked interchangeably, this discrepancy could be explained by the assumption that early remodelling of the left ventricle in hypertensive subjects with a predisposition to sinus node dysfunction affects electrical properties of atria before left ventricular hypertrophy is overt. Ultimately, these patients seek medical attention at early stages receiving optimal treatment for hypertension. Nevertheless, further study is required in order to confirm this hypothesis.
Our results suggest that left ventricular remodelling in hypertensive heart disease may be associated with complete AVB. The Framingham Study established unequivocally that even mild hypertension, if sufficiently prolonged, induces left ventricular hypertrophy. Proper management of these patients is essential for preventing further complications.
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